广州新莱福新材料股份有限公司 2023 年度独立董事述职报告 各位股东及股东代表： 本人马立云，作为广州新莱福新材料股份有限公司（以下简称"公司"）的 独立董事，在任职期间严格按照《公司法》《证券法》《上市公司独立董事管理 办法》等法律、法规以及《公司章程》《独立董事工作制度》等规定，认真行权， 依法履职，做到不受公司大股东、实际控制人或者其他与公司存在利害关系的单 位或个人的影响与左右，充分发挥独立董事的作用，监督公司规范化运作、维护 股东整体利益。现将本人 2023 年度任职期间履行职责的基本情况报告如下： 一、独立董事的基本情况 （一）独立董事工作履历、专业背景及兼职情况 本人马立云：男，1968 年出生，中国国籍，无境外永久居留权，硕士研究生 学历。1987 年 10 月至 1995 年 12 月，历任海军南海舰队训练基地士兵、班长； 1996 年 1 月至 2000 年 7 月，任广东信而立律师事务所律师；2000 年 8 月至 2002 年 7 月，任广东国锋律师事务所律师；2002 年 8 月至今，任广东法制盛邦（东 莞）律师事务所律师；2020 年 9 月至 2023 年 9 月，任公司独立董 ...

中信证券股份有限公司 关于广州新莱福新材料股份有限公司 2023 年度募集资金存放与使用情况的专项核查报告 根据《证券发行上市保荐业务管理办法》《深圳证券交易所上市公司自律监 管指引第 13 号——保荐业务》《深圳证券交易所上市公司自律监管指引第 2 号 ——创业板上市公司规范运作》《上市公司监管指引第 2 号——上市公司募集资 金管理和使用的监管要求》等有关法律法规的要求，中信证券股份有限公司（以 下简称"中信证券"或"保荐人"）作为广州新莱福新材料股份有限公司（以下 简称"新莱福"或"公司"）首次公开发行发行股票的保荐人，对新莱福 2023 年 度募集资金存放和使用情况进行了专项核查，核查的具体情况如下： 一、募集资金基本情况 根据中国证券监督管理委员会签发的《关于同意广州新莱福新材料股份有限 公司首次公开发行股票注册的批复》（证监许可〔2023〕527 号），公司于 2023 年 6 月首次公开发行人民币普通股（A 股）股票 26,230,723 股，每股发行价格为 人民币 39.06 元，募集资金总额为人民币 102,457.20 万元。扣除发行费用（不含 税）后，实际募集资金净额为 94,517.6 ...

证券代码：301323 证券简称：新莱福 公告编号：2024-028 广州新莱福新材料股份有限公司 关于续聘2024年度会计师事务所的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或者重大遗漏。 特别提示： 公司本次续聘天健会计师事务所（特殊普通合伙）为公司 2024 年度审计机 构，符合财政部、国务院国资委、证监会印发的《国有企业、上市公司选聘会计 师事务所管理办法》（财会〔2023〕4 号）的规定。 广州新莱福新材料股份有限公司（以下简称"公司"）于 2024 年 4 月 24 日 召开第二届董事会第六次会议及第二届监事会第六次会议，审议通过了《关于续 聘 2024 年度会计师事务所的议案》，同意续聘天健会计师事务所（特殊普通合 伙）（以下简称"天健会计师事务所"）为公司 2024 年度财务报表和内部控制 审计机构，聘期一年。本事项尚需提交公司 2023 年年度股东大会审议通过。具 体情况如下： 一、拟续聘会计师事务所事项的基本情况 （一）机构信息 1.基本信息 名称：天健会计师事务所（特殊普通合伙） 成立日期：2011 年 7 月 18 日 组织形式：特殊普通 ...

广州新莱福新材料股份有限公司 董事会 2024 年 4 月 25 日 董事会关于 2023 年度独立董事独立性情况的专项意见 根据《上市公司独立董事管理办法》《深圳证券交易所创业板股票上市规则》 《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》 等规定的要求，广州新莱福新材料股份有限公司（以下简称"公司"）董事会就 公司在任独立董事曾德长、杜丽燕、李辉志的独立性情况进行评估并出具如下专 项意见： 经核查上述三位独立董事的任职经历以及签署的相关自查文件，上述人员均 未在公司担任除独立董事以外的任何职务，也均未在公司主要股东公司担任任何 职务，与公司以及主要股东之间不存在利害关系或其他可能妨碍其进行独立客观 判断的关系。因此，公司上述三位独立董事符合《上市公司独立董事管理办法》 《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指 引第 2 号——创业板上市公司规范运作》中对独立董事独立性的相关要求。 广州新莱福新材料股份有限公司 ...

（二）预计日常关联交易类别和金额 1 中信证券股份有限公司 关于广州新莱福新材料股份有限公司 2023 年度日常关联交易确认及 2024 年度 日常关联交易预计的核查意见 中信证券股份有限公司（以下简称"中信证券"或"保荐人"）作为广州新 莱福新材料股份有限公司（以下简称"新莱福"或"公司"）首次公开发行股票 并在创业板上市的保荐人。根据《中华人民共和国公司法》《深圳证券交易所创 业板股票上市规则》《上市公司自律监管指引第 2 号——创业板上市公司规范运 作》等相关法律、法规、规范性文件及《广州新莱福新材料股份有限公司章程》 （以下简称"《公司章程》"）等相关规定，对新莱福 2023 年度日常关联交易 执行情况及 2024 年度日常关联交易预计的事项进行了审慎核查，并出具核查意 见如下： 一、日常关联交易基本情况 （一）日常关联交易概述 新莱福及子公司因日常经营和业务发展的需要，预计公司及子公司 2024 年 与关联人发生的日常关联交易总金额为人民币 5,018.00 万元，关联交易主要内容 涉及采购原材料与服务、出售商品等交易内容等。2023 年度,公司及子公司与关 联人预计发生日常关联交易总金额为 4,4 ...

广州新莱福新材料股份有限公司 关于使用部分闲置自有资金进行委托理财的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或者重大遗漏。 重要内容提示： 1．投资种类：仅限于购买银行结构性存款、大额存单、协定存款或通知存 款、固定收益类产品等产品。 证券代码：301323 证券简称：新莱福 公告编号：2024-026 2．投资金额：公司拟使用最高额度不超过 8.5 亿元的闲置自有资金进行委 托理财。 3．特别风险提示：金融市场受宏观经济政策、经济走势等多方面影响，公 司将根据经济形势及金融市场的变化适时适量地介入相关产品，因此委托理财 的实际收益不可预期，敬请投资者注意投资风险。 广州新莱福新材料股份有限公司（以下简称"公司"）于 2024 年 4 月 24 日召开第二届董事会第六次会议和第二届监事会第六次会议，审议通过了《关 于使用部分闲置自有资金进行委托理财的议案》。为提高资金使用效率，合理 使用闲置自有资金，在不影响公司主营业务正常开展、确保公司经营资金需求 和资金安全的情况下，公司（含全资、控股子公司，下同）拟使用最高额度不 超过 8.5 亿元（含 8.5 亿元）的 ...

广州新莱福新材料股份有限公司 2023 年度会计师事务所履职情况评估报告 一、资质条件 天健会计师事务所(特殊普通合伙)(以下简称"天健")成立于 2011 年,是由 一批资深注册会计师创办的首批具有 A 股企业审计资格的全国性大型会计审计 服务机构。综合实力位列内资所第一，全球排名前二十位。拥有丰富的执业经验 和雄厚的专业能力。包括 A 股、B 股、日股上市公司、大型央企、省属大型国企、 外商投资企业等在内的固定客户 7000 余家，其中上市公司客户 690 余家，新三 板挂牌客户近 300 家。按承办上市公司审计家数排名，在从事证券服务业务会计 师事务所中位居全国第一。近三年通过审核的 IPO 企业在所有同行中名列前茅。 天健首席合伙人王国海,截止 2023 年度末,注册会计师人数 2200 余人，签署过证 券服务业务审计报告的注册会计师人数 836 人。 二、执业记录 1、基本信息 签字项目合伙人：张扬先生，2009 年成为注册会计师，2010 年开始从事上 市公司审计，2013 年开始在天健会计师事务所(特殊普通合伙)执业，2018 年开 始为本公司提供审计服务；近三年签署上市公司审计报告 4 家。 ...

Financial Performance - The company's operating revenue for 2023 was ¥771,185,762.98, representing a 7.88% increase compared to ¥714,877,870.32 in 2022[20]. - The net profit attributable to shareholders for 2023 was ¥138,104,002.67, an increase of 7.96% from ¥127,855,730.73 in 2022[20]. - The net profit after deducting non-recurring gains and losses was ¥121,949,385.80, reflecting an 8.26% increase from ¥112,055,713.17 in 2022[20]. - The cash flow from operating activities decreased by 33.83% to ¥118,407,360.77 from ¥178,946,160.23 in 2022[20]. - The total assets at the end of 2023 reached ¥2,180,207,640.43, a significant increase of 112.82% from ¥1,024,980,547.50 at the end of 2022[20]. - The net assets attributable to shareholders increased by 120.11% to ¥1,998,886,930.98 from ¥908,123,449.47 at the end of 2022[20]. - The company reported a basic earnings per share of ¥1.47, down 9.82% from ¥1.62 in 2022[20]. - The company achieved operating revenue of 771.19 million yuan in 2023, representing a year-on-year growth of 7.88%[67]. - The net profit attributable to shareholders reached 138.10 million yuan, an increase of 7.96% compared to the previous year[67]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was 121.95 million yuan, reflecting an 8.26% year-on-year growth[67]. Investment and Capital Management - The company plans to distribute a cash dividend of 4 RMB per 10 shares to all shareholders, based on the total share capital after deducting repurchased shares[5]. - The company has committed to invest RMB 30,000 million in the composite functional materials production base project, with a cumulative investment of RMB 2,648.61 million, representing 8.83% of the total commitment[121]. - The new rare earth project has a total investment commitment of RMB 13,000 million, with a cumulative investment of RMB 885.71 million, accounting for 6.81% of the total[121]. - The company plans to use up to RMB 900 million of idle raised funds for cash management, with a validity period of 12 months from the approval date by the shareholders' meeting[122]. - The total amount of raised funds used for investment projects is RMB 94,517.64 million, with RMB 8,258.03 million already utilized[121]. - The company has ongoing major non-equity investments in the magnetic materials sector, reflecting its commitment to expanding its product offerings[115]. - The company raised a total of RMB 102,457.20 million through the public offering of 26,230,723 shares at an issue price of RMB 39.06 per share, with a net amount of RMB 94,517.64 million after deducting issuance costs[118]. Research and Development - The company invested 48.5061 million yuan in R&D during the reporting period, representing a year-on-year increase of 28.10%[82]. - The company has over 150 R&D personnel and has engaged experts from renowned institutions to enhance its technological capabilities[82]. - The company is developing new flexible shielding materials for medical and nuclear biochemical radiation protection, aiming to enhance product performance and reduce weight[99]. - The company is focusing on multi-functional magnetic consumer products, expanding its product range to meet diverse customer needs[98]. - The company aims to enhance R&D investment and accelerate technological innovation, focusing on new materials and applications to maintain competitive advantages in technology, cost, and quality[129]. - The R&D team has seen a notable increase in younger personnel, with a 88.24% rise in employees under 30 years old[100]. - The company has developed a flexible, lead-free radiation protection material that is lightweight and environmentally friendly, positioning it at a leading level domestically and advanced internationally[37]. Market and Industry Trends - The company operates in the adhesive ferrite permanent magnet materials sector, which is stable but affected by a sluggish consumer market in 2023[29]. - The global passive components market size was $32.77 billion in 2021 and is projected to reach $42.82 billion by 2027, with a CAGR of 4.56%[32]. - The market for bonded ferrite permanent magnet materials is expected to grow significantly due to increasing demand across various sectors, including electronics and automotive[30]. - The radiation protection industry is experiencing growth due to increased regulatory scrutiny and public awareness of radiation hazards, necessitating advanced protective solutions[35]. - The company is focusing on the growth potential of lead-free radiation protection materials in the market[1]. - The company is expanding its export business, with a focus on key currencies for settlement and overseas sales channels[1]. Governance and Management - The financial report confirms that all board members attended the meeting to review the annual report, ensuring accountability for the report's accuracy[4]. - The board of directors consists of 7 members, including 3 independent directors, ensuring compliance with regulations[1]. - The company has established a performance evaluation and incentive mechanism for its directors and senior management[1]. - The company has maintained a stable financial structure with no reported changes in direct shareholdings among board members and executives[165]. - The company is committed to improving its governance structure and investor relations management[1]. - The company has established an independent financial department with a standardized financial management system, ensuring independent financial decision-making[159]. Employee and Talent Management - The total number of employees at the end of the reporting period is 1,048, with 400 in the parent company and 437 in major subsidiaries[193]. - The company has a total of 1,055 employees receiving salaries during the reporting period[193]. - The professional composition includes 648 production personnel, 66 sales personnel, and 196 technical personnel[193]. - The company has established training programs to develop technology innovation talents through various methods[197]. - The company emphasizes competitive salaries and fair performance evaluations to ensure internal equity and external competitiveness[196]. Risks and Challenges - The company recognizes the risk of intensified industry competition and plans to enhance its technological reserves and product quality to address this challenge[134]. - The company is at risk of losing its high-tech enterprise status, which currently allows it to enjoy a 15% corporate income tax rate, if it fails to renew its certification[137]. - The company faces risks related to investment projects funded by raised capital, which may not achieve expected returns due to market changes and technological replacements[140]. - The company will closely monitor exchange rate trends and optimize its foreign currency asset-liability structure to minimize exchange rate risks[139]. Future Outlook - The company has set a revenue guidance of 1.5 billion RMB for the next fiscal year, projecting a growth rate of 25%[169]. - New product launches are expected to contribute an additional 300 million RMB in revenue, with a focus on innovative materials[169]. - The company plans to pursue strategic acquisitions to bolster its technology capabilities, with a budget of 500 million RMB allocated for potential targets[169]. - A new manufacturing facility is set to be operational by Q3 2024, expected to increase production capacity by 30%[169]. - The management team emphasized a commitment to sustainability, aiming for a 40% reduction in carbon emissions by 2025[169].

Financial Performance - The company's revenue for Q1 2024 reached ¥190,176,764.71, representing a 15.75% increase compared to ¥164,294,321.64 in the same period last year[5] - Net profit attributable to shareholders was ¥36,289,201.26, up 28.38% from ¥28,267,503.72 year-on-year[5] - The cash flow from operating activities increased by 56.00%, amounting to ¥14,973,562.13 compared to ¥9,598,563.07 in the previous year[5] - The total operating revenue for Q1 2024 was CNY 190,176,764.71, an increase of 15.7% compared to CNY 164,294,321.64 in Q1 2023[24] - Net profit for Q1 2024 reached CNY 36,279,345.90, representing a 26.0% increase from CNY 28,809,005.50 in Q1 2023[26] - The total comprehensive income for Q1 2024 was CNY 35,686,417.32, compared to CNY 28,716,666.94 in the same period last year, marking an increase of 24.5%[26] Expenses and Investments - Research and development expenses surged by 82.93%, totaling ¥16,822,921.67, reflecting the company's increased investment in R&D[9] - Research and development expenses for Q1 2024 were CNY 16,822,921.67, up 83.5% from CNY 9,196,604.15 in Q1 2023, indicating a strong focus on innovation[24] - The company experienced a 54.10% increase in selling expenses, amounting to ¥8,447,897.63, primarily due to increased business volume and related costs[9] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 9,426[11] - The largest shareholder, Guangzhou Yishang Investment Co., Ltd., holds 13.72% of the shares, totaling 14,392,500 shares[12] - The second-largest shareholder, Jun Cai Co., Ltd., holds 7.51% of the shares, totaling 7,884,000 shares[12] - The company has no changes in the number of shares held by the top 10 shareholders due to margin trading activities[12] Share Repurchase - The company repurchased shares, resulting in a significant cash outflow of ¥34,293,332.17 in financing activities, a 3355.97% increase in cash outflow compared to the previous period[9] - The company repurchased a total of 1,076,390 shares, accounting for 1.0259% of the total share capital, with a total expenditure of approximately RMB 32.47 million[15][16] - The maximum transaction price during the repurchase was RMB 32.98 per share, while the minimum was RMB 27.73 per share[16] - The repurchase plan was approved on February 6, 2024, with a budget between RMB 30 million and RMB 60 million for the buyback[15] - The company plans to use the repurchased shares for future employee stock ownership plans or equity incentive plans[15] Assets and Liabilities - The total assets at the end of the reporting period were ¥2,139,821,510.25, a decrease of 1.85% from ¥2,180,207,640.43 at the end of the previous year[5] - The company's cash and cash equivalents decreased to RMB 292,326,068.32 from RMB 398,213,513.90, reflecting a decline of approximately 26.6%[22] - Total current liabilities decreased to RMB 93,105,666.25 from RMB 138,468,900.43, a reduction of about 32.8%[23] - The company's total equity increased slightly to RMB 2,021,164,628.12 from RMB 2,015,934,369.19, indicating a growth of approximately 0.6%[23] - The company reported a total non-current asset value of RMB 1,348,713,918.09, up from RMB 1,317,544,608.42, representing an increase of about 2.4%[23] - The company’s accounts receivable decreased to RMB 134,935,299.79 from RMB 160,547,428.02, a decline of approximately 16%[22] - The company’s inventory remained relatively stable, with a slight decrease from RMB 130,069,843.09 to RMB 130,064,563.68[22] - The company’s total liabilities decreased to RMB 118,656,882.13 from RMB 164,273,271.24, a reduction of about 27.7%[23] - The company’s retained earnings increased to RMB 425,606,218.16 from RMB 389,317,016.89, reflecting a growth of approximately 9.3%[23] Future Outlook and Strategies - Future outlook includes a projected revenue growth of 10% for the next quarter, driven by new product launches[33] - The company is investing 200 million RMB in R&D for new technologies aimed at enhancing product performance[33] - Market expansion plans include entering two new international markets by the end of 2024[33] - New product lines are anticipated to contribute an additional 300 million RMB in revenue over the next year[33] - The company has set a target to reduce production costs by 8% through operational improvements[33] - A new marketing strategy is being implemented, focusing on digital channels to increase brand awareness and customer engagement[33] Corporate Actions - The company approved the 2024 Restricted Stock Incentive Plan, granting 3,362,000 shares at a price of RMB 15.40 per share to 206 eligible participants[20] - The report does not indicate any mergers or acquisitions during the reporting period[13] - The company has completed a strategic acquisition of a competitor, expected to increase market share by 5%[33] - The company has not disclosed any new product developments or market expansion strategies in this report[13]

目 录 一、非经营性资金占用及其他关联资金往来情况的专项 审计说明…………………………………………………………第 1—2 页 二、非经营性资金占用及其他关联资金往来情况汇总表………………第 3 页 非经营性资金占用及其他关联资金往来情况的 二、管理层的责任 新莱福公司管理层的责任是提供真实、合法、完整的相关资料，按照《上市 公司监管指引第 8 号——上市公司资金往来、对外担保的监管要求》（证监会公 告〔2022〕26 号）和《深圳证券交易所创业板上市公司自律监管指南第 1 号— —业务办理（2023 年 12 月修订）》（深证上〔2023〕1204 号）的规定编制汇总 表，并保证其内容真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏。 第 1 页 共 3 页 专项审计说明 天健审〔2024〕5-42 号 广州新莱福新材料股份有限公司全体股东： 我们接受委托，审计了广州新莱福新材料股份有限公司（以下简称新莱福公 司）2023 年度财务报表，包括 2023 年 12 月 31 日的合并及母公司资产负债表， 2023 年度的合并及母公司利润表、合并及母公司现金流量表、合并及母公司所 有者权益变动表，以及财务报 ...